Welcome to the latest episode of Talking Meds and the PrescQIPP podcast, engaging conversations about medicines-related dilemmas. Today, your host Jonathan Underhill, Medicines Clinical Adviser at PrescQIPP, talks to Philip Newland-Jones about new treatments for obesity and the updated NICE guideline from January 2025.
Philip is a Consultant Pharmacist in Diabetes and Endocrinology and leads a large dynamic team at University Hospital Southampton. He works at a National level on various committees including being the lead pharmacist for the NHS England Diabetes and Endocrinology Clinical Reference Group.
Jonathan and Philip discuss various challenging and sometimes controversial issues around the management of obesity. The evidence for the effectiveness of some of the medicines options is impressive, but they are not without side effects - careful and appropriate use is key. Many new medicines are in development and Philip gives us an insight into what we can expect on the horizon.
PrescQIPP resources mentioned in this episode:
Useful NICE obesity resources:
Other resources mentioned in this episode:
